---
title: "HOEKMAN JOHN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0190964a-4369-569a-bc28-592f9ea034f5
json: https://whiteintel.dev/api/public/dossier/0190964a-4369-569a-bc28-592f9ea034f5
identifier: sec:0001855676
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# HOEKMAN JOHN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001855676`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0190964a-4369-569a-bc28-592f9ea034f5  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0190964a-4369-569a-bc28-592f9ea034f5  

## Ownership & control

### Holdings / subsidiaries

- **IMPEL NEUROPHARMA INC** (officer) — https://whiteintel.dev/entity/32a51ecc-2194-5141-922b-0b01ac58d5f7

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **HOEKMAN JOHN**. Human view: https://whiteintel.dev/entity/0190964a-4369-569a-bc28-592f9ea034f5 · Structured JSON: https://whiteintel.dev/api/public/dossier/0190964a-4369-569a-bc28-592f9ea034f5._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._